Skip to content

ICAAC: Factors unrelated to HIV or side-effects of HIV treatment major cause of illness in French cohort

ICAAC: TB patients with good CD4 cell counts can safely defer HIV treatment

Improving the diagnosis of active TB in people with HIV

ICAAC: Nevirapine and rifampicin can be safely used together

ICAAC: Moxifloxacin as effective as ethambutol in TB treatment

Advocacy groups demand equal HIV treatment access for injecting drug users

HIV-positive injecting drug users who are infected with HTLV-II less are less likely to progress to AIDS

Previous immune damage and response to HIV treatment associated with TB after starting antiretrovirals

HIV treatment reduces risk of TB in South Africa more than previously thought